Tamoxifen advances puberty in the White Leghorn hen.
1. Tamoxifen (TAM) administration advances puberty in cockerels. In the present study the effect of TAM administration on the sexual development of White Leghorn hens was studied. 2. Two-week-old White Leghorn females were injected intramuscularly with TAM on alternate days at doses of 0.1 mg (0.1 TM), 1 mg (1TM), 5 mg (5TM) and 10 mg/kg body weight (10TM) respectively, while the controls were injected with maize oil (vehicle). The experiment was terminated at 23 weeks of age, when all the control hens laid eggs. Sample autopsies were made on chicks of 6, 14 and 23 weeks of age. 3. Body growth was not affected by any of the treatments. 4. Comb growth was accelerated by all doses of TAM, while hematocrit increased in the 1TM, 5TM and 10TM hens. 5. Egg laying advanced in the 0.1TM and 1TM birds, was delayed in 5TM hens and did not occur at all in the 10TM females. 6. TAM caused a precocious increase in plasma oestrogen and androgen, suppressed adiposity in a dose-related manner and, at low doses, advanced the development of the gonadal system. 7. At 23 weeks of age, when the gonadal system of the controls was fully active, TAM caused a dose-related depression in abdominal fat, liver, ovary, and oviduct weights, plasma total lipids and calcium concentrations and a dose-related increase in plasma oestrogen and androgen titres, and comb weight. 8. It seems that TAM increased gonadotropic activity and its androgen stimulating action, but suppressed peripheral signs of the elevated plasma oestrogen titres. Low doses of TAM enhanced gonadotropic activity and egg laying but the antioestrogenic effect depressed development of the gonadal system, suppressing egg production when high doses were administered. It therefore seems that oestrogens are necessary for normal ovarian development in hens.
Jaccoby
S
S
Department of Animal Science, Faculty of Agriculture, Hebrew University of Jerusalem, Rehovot, Israel.
Snapir
N
N
Rozenboim
I
I
Arnon
E
E
Meidan
R
R
Robinzon
B
B
D000728:Androgens / Q000097:blood; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002118:Calcium / Q000097:blood; D002645:Chickens / Q000254:growth & development* / Q000502:physiology; D003129:Comb and Wattles / Q000187:drug effects / Q000254:growth & development; D004305:Dose-Response Relationship, Drug; D004967:Estrogens / Q000097:blood; D005260:Female; D006400:Hematocrit / Q000662:veterinary; D007273:Injections, Intramuscular / Q000662:veterinary; D008055:Lipids / Q000097:blood; D008099:Liver / Q000187:drug effects; D009929:Organ Size / Q000187:drug effects; D010053:Ovary / Q000187:drug effects / Q000254:growth & development; D010057:Oviducts / Q000187:drug effects / Q000254:growth & development; D010058:Oviposition / Q000187:drug effects; D012741:Sexual Maturation / Q000187:drug effects*; D013629:Tamoxifen / Q000008:administration & dosage / Q000494:pharmacology*
D000728:Androgens; D004967:Estrogens; D008055:Lipids; D013629:Tamoxifen; D002118:Calcium